Ming-Chin Yu

20PUBLICATIONS

102CO-AUTHORS

Predictive and prognostic markersMolecular targetsTraditional Chinese medicine and treatmentsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 01, 2026

Machine-Learning Based Prognostic Model for Predicting Early Recurrence in HCC Patients After Hepatectomies: An Explainable AI Approach.

|Jan 03, 2026

SOX4-STAT6-MTHFD2 axis drives hepatocellular carcinoma progression and treatment resistance.

Chia-Lung Tsai, Ming-Chin Yu, Cheng-Lung Hsu

|Jan 01, 2026

Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha-Fetoprotein-Negative Patients With Cirrhotic Nodules.

Li-Jun Chang, Ming-Chin Yu, Wei-Chen Lee

|Oct 15, 2025

The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.

Hsin-Chou Yang, Pui-Yan Kwok, Ling-Hui Li

|Aug 26, 2025

NRF2-SOX4 complex regulates PSPH in hepatocellular carcinoma and modulates M2 macrophage differentiation.

Chi-Neu Tsai, Ming-Chin Yu, Yun-Shien Lee

|Apr 28, 2025

PLT012, a Humanized CD36-Blocking Antibody, Is Effective for Unleashing Antitumor Immunity Against Liver Cancer and Liver Metastasis.

Sheue-Fen Tzeng, Yi-Ru Yu, Jaeoh Park

Pageof 4

Frequent Collaborators

Chao-Wei Lee

Sey-En Lin

Heng-Yuan Hsu

Tsung-Han Wu

Chia-Lung Tsai

Chi-Neu Tsai

Song-Fong Huang

Yun-Shien Lee

Wei-Chen Lee

Sen-Yung Hsieh

Frequent Collaborators

Chao-Wei Lee

Sey-En Lin

Heng-Yuan Hsu

Tsung-Han Wu